Although 0.02 μg of both LH-Fc and LH-Fc-HY52W markedly inhibited tumor growth in SCID mice (Fig. 5A), none of the LH-Fc mutants tested and 0.002 μg LH-Fc showed intense antitumor effects (Fig. 5B). This evidence concerns the gene PLOD1 and neoplasm.